Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by ProfCorneliuson May 02, 2020 12:37am
687 Views
Post# 30978815

My hope for Aphria

My hope for Aphria Is that someday institutional investors and multinationals will as attracted to Aphria as women are to Webswinger. If that were the case Aphria would be $25 right now. The good news is that the next few Quarters fundamentals will swing the banks, funds and equity partners our way. The ones that aren't already interested that is. I still expect material news from Europe but the timing of which is skewed for obvious reasons. My understanding is that the deal would've been signed and put to bed by now if it wasn't for the COVID 19 crisis. Aphria $14 by year's end and $25 by the end of 2021. Prof
<< Previous
Bullboard Posts
Next >>